(Q73132934)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9060912%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

title

Can a class III antiarrhythmic drug improve electrical defibrillation efficacy during ventricular fibrillation? (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9060912%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

author name string

Y Murakawa

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9060912%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

T Yamashita

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9060912%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

Y Kanese

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9060912%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

M Omata

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9060912%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

language of work or name

English

0 references

publication date

1 March 1997

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9060912%20AND%20SRC:MED&resulttype=core&format=json

Journal of the American College of Cardiology

1 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9060912%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

volume

29

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9060912%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9060912%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

page(s)

688-692

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9060912%20AND%20SRC:MED&resulttype=core&format=json

Evaluation of antiarrhythmic drugs on defibrillation energy requirements in dogs. Sodium channel block and action potential prolongation

1 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2896%2900559-1

7 January 2021

Lidocaine causes a reversible, concentration-dependent increase in defibrillation energy requirements.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2896%2900559-1

7 January 2021

Effects of encainide and its metabolites on energy requirements for defibrillation

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2896%2900559-1

7 January 2021

Effect of lidocaine and bretylium on energy requirements for transthoracic defibrillation: experimental studies.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2896%2900559-1

7 January 2021

Effect of recainam on the energy required for ventricular defibrillation in dogs as assessed with implanted electrodes

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2896%2900559-1

7 January 2021

Effects of flecainide on defibrillation thresholds in the anesthetized dog.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2896%2900559-1

7 January 2021

Effect of antiarrhythmic drugs on defibrillation threshold: case report of an adverse effect of mexiletine and review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2896%2900559-1

7 January 2021

Prolongation of intraventricular conduction time associated with fatal [correction of fetal] impairment of defibrillation efficiency during treatment with class I antiarrhythmic agents

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2896%2900559-1

7 January 2021

Effects of procainamide and lidocaine on defibrillation energy requirements in patients receiving implantable cardioverter defibrillator devices.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2896%2900559-1

7 January 2021

Oral clofilium produces sustained lowering of defibrillation energy requirements in a canine model

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2896%2900559-1

7 January 2021

Effects of MS-551, a new class III antiarrhythmic drug, on action potential and membrane currents in rabbit ventricular myocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2896%2900559-1

7 January 2021

Effect of pentobarbital anesthesia on ventricular defibrillation threshold in dogs

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2896%2900559-1

7 January 2021

Flecainide acetate does not alter the energy requirements for direct ventricular defibrillation using sequential pulse defibrillation in pigs

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2896%2900559-1

7 January 2021

Effects of flecainide on defibrillation threshold in pigs.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2896%2900559-1

7 January 2021

Clinical characteristics and outcome of patients with high defibrillation thresholds. A multicenter study

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2896%2900559-1

7 January 2021

Effects of chronic amiodarone therapy on defibrillation threshold

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2896%2900559-1

7 January 2021

Channel specificity in antiarrhythmic drug action. Mechanism of potassium channel block and its role in suppressing and aggravating cardiac arrhythmias

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2896%2900559-1

7 January 2021

Prospective evaluation of initially ineffective defibrillation pulses on subsequent defibrillation success during ventricular fibrillation in survivors of cardiac arrest

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2896%2900559-1

7 January 2021

Dispersion of refractoriness in canine ventricular myocardium. Effects of sympathetic stimulation.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2896%2900559-1

7 January 2021

Dispersion of 'refractoriness' in noninfarcted myocardium of patients with ventricular tachycardia or ventricular fibrillation after myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2896%2900559-1

7 January 2021

Blood flow and perfusion pressure during open-chest versus closed-chest cardiopulmonary resuscitation in pigs.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2896%2900559-1

7 January 2021

A technique revisited: hemodynamic comparison of closed- and open-chest cardiac massage during human cardiopulmonary resuscitation.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2896%2900559-1

7 January 2021

10.1016/S0735-1097(96)00559-1

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9060912%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

1 reference